Amivantamab and Hyaluronidase Approved as the only EGFR-targeted Therapy that can be Administered once a Month Archives

Danielle Garcia - February 17, 2026

Peter Hofland - June 30, 2026

Editorial Team - June 23, 2026

Editorial Team - June 23, 2026

Peter Hofland - June 23, 2026

Editorial Team - June 19, 2026

Healthy Snack Trend Among Gen Alpha Families Drives Need for Specialized Packaging as Plexpack Delivers Equipment Solutions August 17, 2026
A growing share of parents shopping for Gen Alpha households now prioritize natural ingredients and high-protein content in snacks. This shift is driving food brands to seek packaging equipment suited to healthy snacks that preserves freshness without added preservatives. TORONTO, Aug....
Expert Radiology Named No. 602 on the 2026 Inc. 5000 List, the Most Prestigious Ranking of America's Fastest-Growing Private Companies August 17, 2026
San Juan-based subspecialty teleradiology practice earns a place among America's fastest-growing private companies after achieving 576% three-year revenue growth. SAN JUAN, Puerto Rico, Aug. 17, 2026 /PRNewswire-PRWeb/ -- Expert Radiology today announced it has been ranked No. 602 on the...
Knotts Family Agency Reaffirms 24/7 Parent Support Guarantee With 15-Minute Response Time for Riverside County Foster Families August 17, 2026
Knotts Family Agency has reaffirmed its 24/7 Parent Support Guarantee for foster families across Riverside County, backing the commitment with a 15-minute average response time for every after-hours call the agency receives. REDLANDS, Calif., Aug. 17, 2026 /PRNewswire-PRWeb/ -- Families...

Tag: Amivantamab and Hyaluronidase Approved as the only EGFR-targeted Therapy that can be Administered once a Month